Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel combinations of anticancer agents reported by Angiogene researchers

March 7, 2005

New immunoglobulin E (IgE) production inhibitors and their use disclosed by Celltech

March 4, 2005

Celltech discloses the development of novel p38 MAP kinases for rheumatoid arthritis

March 4, 2005

Novel anti-hepatitis C virus (HCV) agents discovered at Enanta

March 4, 2005

Two series of serotonin reuptake inhibitors reported by Merck

March 4, 2005

Controlled release formulations for antiinfective therapy claimed

March 4, 2005

New treatment for varicose veins described in patent literature

March 3, 2005

AstraZeneca claims novel Aurora kinase inhibitors for the treatment of cancer

March 3, 2005

New cannabinoid CB1 receptor modulators prepared and tested at AstraZeneca

March 3, 2005

New opioid receptor antagonists for gastrointestinal dysfunction disclosed by Adolor

March 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...